Male sex is associated with a higher incidence of soft tissue and bone sarcomas, particularly in childhood, though the underlying biological mechanisms remain largely unexplored.
This narrative review highlights the male sex predilection in soft tissue and bone sarcomas, particularly in childhood, and emphasizes the need to explore the underlying biological mechanisms to inform prevention and treatment.
Sarcomas, uncommon malignancies, stem from mesenchymal tissues, distinct from epithelial tissues, originating in the embryonic mesodermal layer. These sarcomas have been categorized as either bone or soft tissue sarcomas, depending on their originating tissue. The majority of sarcomas occur sporadically with their etiology being unknown, but there are several, well-established genetic predisposition syndromes and some environmental exposures associated with specific sarcomas. Recently, many studies have shown that sarcomas, in analogy with colorectal, skin, head and neck, esophageal, lung, and liver carcinomas, also have a male sex predilection. Significant gender differences have already been observed in childhood sarcomas. Among the tumors strongly associated with the male sex, childhood sarcomas have been identified as being particularly sensitive to the biological differences between the sexes, with special regard to soft tissue sarcomas. As the biological mechanisms underlying the sex differences in the incidence of soft tissue sarcomas remain largely unexplored, this review aims to highlight the factors underlying these differences to inform prevention and treatment.
Cosci et al. (Sun,) conducted a review in Soft Tissue and Bone Sarcoma. Male sex is associated with a higher incidence of soft tissue and bone sarcomas, particularly in childhood, though the underlying biological mechanisms remain largely unexplored.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: